Catalyst Wire Dossier Catalyst Wire Dossier

Ompenaclid

Ompenaclid · Inspirna, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Ompenaclid, covering 2025-04-03 to 2026-02-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate Ompenaclid Combined With FOLFIRI Plus Bevacizumab in Advanced/Metastatic Colorectal Cancer [Phase 2]

See pricing